Viviane Luangphakdy

Cleveland Clinic Lerner College of Medicine

Papers

4

Total Citations

59

H-Index

3

About

Viviane Luangphakdy is a biomedical engineer and researcher specializing in the automation of cell manufacturing processes, with a particular focus on induced pluripotent stem cell (iPSC) technologies and regenerative medicine. Her work sits at the critical intersection of robotics, imaging, and cell therapy, addressing one of the most pressing bottlenecks in translating stem cell science into clinical reality: scalable, reproducible production. Luangphakdy's most impactful contribution to date is her work on automating iPSC generation for autologous photoreceptor cell replacement therapy, offering a promising pathway for patients suffering from inherited retinal degeneration — a leading cause of irreversible vision loss. Garnering 30 citations since 2023, this study underscores the transformative potential of high-throughput parallel production systems in cell therapy. Her complementary research on automated colony segmentation and in-process clone characterization further demonstrates her commitment to building intelligent quality-control frameworks essential for clinical-grade manufacturing. More recently, her investigations into mesenchymal stromal cell fabrication highlight her expanding focus on improving reproducibility across diverse cell therapy platforms. Collectively, Luangphakdy's work is establishing foundational tools that could accelerate the safe, scalable delivery of life-changing regenerative therapies to patients worldwide.

Research Focus

Key Achievements

3
H-Index
4
Papers
59
Total Citations
15
Avg Citations/Paper
🏆 Most Cited Paper
Automating iPSC generation to enable autologous photoreceptor cell replacement therapy
30 citations · 2023
📈 Most Prolific Year: 2023 (2 Papers)
🤝 Key Collaborators: 16
🏛 Institutions: Cleveland Clinic Lerner College of Medicine

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 16 days ago